[Cefotaxime-resistant shiga toxin-producing Escherichia coli O26 : H11 isolated from a patient with diarrhea]

Kansenshogaku Zasshi. 2005 Mar;79(3):161-8. doi: 10.11150/kansenshogakuzasshi1970.79.161.
[Article in Japanese]

Abstract

A shiga toxin-producing Escherichia coli (STEC) O26 strain resistant to cefotaxime (CTX) and cefpodoxime (but not ceftazidime) was isolated from the faecal sample of a 17-year-old outpatient with diarrhea. The double disk synergy test, twin test, polymerase chain reaction and sequence analysis confirmed that the strain produced CTX-M-3 type extended-spectrum beta-lactamase (ESBL). Conjugation experiment results suggested that the CTX resistance in this strain was determined by an approximately 85kbp plasmid that was readily transferable to a susceptible recipient E. coli strain. This is the first report from Japan of CTX-M-3type ESBL-producing STEC O26.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / pharmacology*
  • Cefotaxime / pharmacology*
  • Diarrhea / microbiology*
  • Escherichia coli / drug effects*
  • Escherichia coli / isolation & purification
  • Escherichia coli / metabolism
  • Female
  • Humans
  • Shiga Toxin / biosynthesis*
  • beta-Lactam Resistance* / genetics

Substances

  • Anti-Bacterial Agents
  • Shiga Toxin
  • Cefotaxime